Federated Hermes, Inc. Gritstone Bio, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $1,056 - $2,590	597 New	597 $1,000
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $2,528 - $3,172	-311 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.07 - $27.11 $293 - $1,951	72 Added 30.13%	311 $3,000
Q4 2020 Feb 12, 2021	BUY	$2.57 - $4.22 $614 - $1,008	239 New	239 $1,000
Q2 2019 Aug 14, 2019	SELL	$9.2 - $15.7 $3,449 - $5,887	-375 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$9.97 - $18.96 $3,738 - $7,110	375 New	375 $5,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.